O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium Hexafluorophosphate

We are O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium Hexafluorophosphate CAS:94790-37-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium Hexafluorophosphate
CAS.NO:94790-37-1
Synonyms:[benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium,hexafluorophosphate;HBTU
Molecular Formula:C11H16F6N5OP
Molecular Weight:379.24200
 
Physical and Chemical Properties:
Melting point:200oC;
Flash point:200oC;
 
HS Code: 2933990099
UN No.: UN3465
Hazard class: 6.1 categories 
Packing level: Class II
 
Specification:
Appearance:Off-white to white crystalline powder
Purity(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent

O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium Hexafluorophosphate


Related News: An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug.Ácido tranexámico CAS:701-54-2 Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.N-(2-Nitrophenyl)-3-oxobutanamide CAS:90915-86-9 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.ethyl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate CAS:180468-42-2 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.

Related Products
Product Name
6-Fluoronicotinic acid View Details
2,4,6-Triisopropylbenzenesulfonyl chloride View Details
Methyl (2E)-3-[3-(trifluoromethyl)phenyl]acrylate View Details
3-Bromo-5-methylpicolinic acid manufacturer 5-chlorouracil manufacturer pyridin-2-ol manufacturer N-Carbobenzyloxy-L-valine manufacturer 2,3,4-Trifluorobenzoic acid manufacturer